OTTAWA - A class-action lawsuit against pharmaceutical giant Pfizer Canada over its anti-smoking drug Champix will proceed, an Ontario Superior Court has ruled. The Ontario court certified the ...

MONTREAL, CANADA – Pfizer Canada’s pharmaceutical division is among Canada’s best companies to work for, says a closely watched annual survey by Report on Business Magazine. The magazine, published by ...

LP.8.1 variant adapted COVID-19 vaccine COMIRNATY is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks. This season's ...

With the approval of ABRYSVO® for adults aged 18+, there is now a way to help protect against RSV in a population that previously did not have vaccination options. KIRKLAND, QC, Oct. 21, 2025 /CNW/ - ...

TORONTO, ON — Canadian health officials said Wednesday they have become the first to approve Pfizer’s COVID-19 vaccine for ages as young as 12. Dr. Supriya Sharma, chief medical adviser at Health ...

Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...

OTTAWA, Nov 8 (Reuters) - Canada's Supreme Court struck down the patent on global pharmaceuticals giant Pfizer Inc's Viagra erectile dysfunction drug on Thursday and opened the door to generic ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

This week, the FDA approved a label change on Depo Provera, requiring its maker, Pfizer, to warn women about links between use of the birth control injection and brain tumors known as meningiomas. The ...

Canadians looking to get a COVID-19 vaccine at local pharmacies may run into some trouble. Pfizer Canada says it has placed temporary limits on orders of one of its COVID shots at community pharmacies ...

This week, the FDA approved a label change on Depo Provera, requiring its maker, Pfizer, to warn women about links between use of the birth control injection and brain tumors known as meningiomas.